Search Results

• • 14 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Tests de depistage du rapport international normalise et du temps de cephaline activee.

  Authors:Nicholas L.J. Chornenki, Michael Fralick, and Michelle SholzbergFrom:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 43) Peer-Reviewed

  Nov. 7, 2022782 words Article 1710L1 Le rapport international normalise (RIN) et le temps de cephaline activee (TCA) offrent une utilite clinique limitee On ne devrait employer le RIN et le TCA que pour des indications cliniques precises (consultez...

• International normalized ratio and activated partial thromboplastin time testing.

  Authors:Nicholas L.J. Chornenki, Michael Fralick, and Michelle SholzbergFrom:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 33) Peer-Reviewed

  Aug. 29, 2022614 words Article 2140L1 International normalized ratio (INR) and activated partial thromboplastin time (aPTT) have limited clinical utility The INR and aPTT should be used only for specific clinical indications (see Appendix 1, available at...

• Reconnaitre, traiter et signaler les cas de thrombocytopenie immunitaire thrombotique induite par un vaccin.

  Authors:Michelle Sholzberg, Donald M. Arnold, and Andreas LaupacisFrom:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 27) Peer-Reviewed

  July 5, 20212,134 words Article 1740LDans un rapport connexe, Jones et ses collaborateurs decrivent le cas d'un homme de 63 ans qui a presente des thromboses des arteres poplitees et pulmonaires (1). Ces thromboses etaient probablement imputables a une...

• Coagulopathie associee a la COVID-19

  Authors:Stephanie G. Lee, Michael Fralick, and Michelle SholzbergFrom:CMAJ: Canadian Medical Association Journal (Vol. 192, Issue 45) Peer-Reviewed

  Nov. 9, 2020756 words Article 2020L1 Chez 20 % a 55 % des patients hospitalises pour la maladie a coronavirus 2019 (COVID-19), les analyses de laboratoire montrent des signes de coagulopathie La coagulopathie est en correlation avec la gravite de la...

• Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy

  Authors:Michelle Sholzberg and Yan XuFrom:JAMA, The Journal of the American Medical Association (Vol. 320, Issue 14) Peer-Reviewed

  Oct. 9, 201874 words Report

   Citation Only

• Effectiveness of therapeutic heparin v prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill inpatients with covid-19.

  Authors:Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, Musaad al- Hamzah, Lisa Baumann Kreuziger, Fionnuala Ni Ainle, et al.From:British Medical Journal (Vol. 375, Issue 8312) Peer-Reviewed

  Oct. 30, 202160 words Report

   Citation Only

• Coagulopathy associated with COVID-19

  Authors:Stephanie G. Lee, Michael Fralick, and Michelle SholzbergFrom:CMAJ: Canadian Medical Association Journal (Vol. 192, Issue 21) Peer-Reviewed

  May 25, 2020643 words Article 1920L1 About 20%-55% of patients admitted to hospital for coronavirus disease 2019 (COVID-19) have laboratory evidence of coagulopathy Coagulopathy correlates with severity of COVID-19 and may include increased D-dimer...

• The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective

  Authors:Brendan Wood, Barto Nascimento, Sandro Rizoli, Michelle Sholzberg, Amanda McFarlan, Andrea Phillips, et al.From:Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine (Vol. 25, Issue 1) Peer-Reviewed

  Aug. 2, 20172,600 words Report 1540LBackground The anticoagulated trauma patient presents a particular challenge to the critical care physician. Our understanding of these patients is defined and extrapolated by experience with patients on warfarin...

• Five things to know about ... direct oral anticoagulants and the bleeding patient

  Authors:Brendan Wood, Michelle Sholzberg, and Alun AckeryFrom:CMAJ: Canadian Medical Association Journal (Vol. 188, Issue 3) Peer-Reviewed

  Feb. 16, 2016567 words Drug overview 1490LDirect oral anticoagulant agents are now routinely used for the prevention of stroke in nonvalvular atrial fibrillation 1 Rivaroxaban, apixaban and dabigatran are now commonly used as alternatives to vitamin K...

• A 24-year-old woman with heavy menstrual bleeding

  Authors:Michelle Sholzberg, Jerome Teitel, and Lisa K. HicksFrom:CMAJ: Canadian Medical Association Journal (Vol. 189, Issue 22) Peer-Reviewed

  June 5, 20171,187 words Case study, Report 1650LA 24-year-old woman presents to her family physician for follow-up of bloodwork for a history of heavy menstrual bleeding from the onset of menarche. She also describes easy bruising and recurrent episodes of epistaxis....

• Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia.

  Authors:Michelle Sholzberg, Donald M. Arnold, and Andreas LaupacisFrom:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 24) Peer-Reviewed

  June 14, 20211,824 words Article 1870LIn a related case report, Jones and colleagues describe a 63-year-old man who developed thromboses in his popliteal and pulmonary arteries. (1) The patient's thromboses were likely caused by vaccine-induced immune...

• Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders

  Authors:Sumedha Arya, Pamela Wilton, David Page, Laurence Boma-Fischer, Georgina Floros, Katie N. Dainty, et al.From:PLoS ONE (Vol. 15, Issue 2) Peer-Reviewed

  Feb. 20, 20204,917 words Survey 1620LIntroduction The ways in which social determinants of health affect patients with inherited bleeding disorders remains unclear. The objective of this study was to understand healthcare provider perspectives regarding...

• The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation

  Authors:Michelle Sholzberg, Tara Gomes, David N. Juurlink, Zhan Yao, Muhammad M. Mamdani, and Andreas LaupacisFrom:PLoS ONE (Vol. 11, Issue 2) Peer-Reviewed

  Feb. 25, 20164,981 words Report 1830LImportance Without third-party insurance, access to marketed drugs is limited to those who can afford to pay. We examined this phenomenon in the context of anticoagulation for patients with nonvalvular atrial...

• The authors respond to "Is referral necessary for abnormal bleeding?"

  Authors:Michelle Sholzberg, Jerome Teitel, and Lisa K. HicksFrom:CMAJ: Canadian Medical Association Journal (Vol. 189, Issue 44) Peer-Reviewed

  Nov. 6, 2017473 words Report 1450LWe thank Dr. Giles (1) for her interest and commentary on our article. (2) For clarification, Drs. Sholzberg, Teitel and Hicks are hematologists, and Dr. Sholzberg is the medical director of the coagulation...